Back to GetFilings.com



 

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

ý  QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934.

 

For the quarterly period ended September 30, 2002

 

o  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934

 

For the transition period from                       to                      .

 

Commission File Number 0-21221

 

MICROVISION, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Washington

 

91-1600822

(State or Other Jurisdiction of Incorporation
or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

19910 North Creek Parkway, Bothell, Washington  98011-3008

(Address of Principal Executive Offices)

 

 

 

Issuer’s telephone number, including area code: (425) 415-6847

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ý Yes    o No

 

As of October 31, 2002, 15,154,400 shares of the Company’s common stock, no par value, were outstanding.

 

 



 

PART I

FINANCIAL INFORMATION

 

Item 1 -

Financial Statements (unaudited)

 

 

Consolidated Balance Sheet as of September 30, 2002 and December 31, 2001

 

 

 

Consolidated Statement of Operations for the three and nine months ended September 30, 2002 and 2001

 

 

 

Consolidated Statement of Comprehensive Loss for the three and nine months ended September 30, 2002 and 2001

 

 

 

Consolidated Statement of Cash Flows for the nine months ended September 30, 2002 and 2001

 

 

 

Notes to Consolidated Financial Statements

 

 

Item 2 -

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

Item 3 -

Quantitative and Qualitative Disclosures About Market Risk

 

 

Item 4 –

Controls and Procedure

 

 

PART II

OTHER INFORMATION

 

 

Item 6 -

Exhibits and Reports on Form 8-K

 

2



 

Microvision, Inc.

 

Consolidated Balance Sheet

(In thousands)

 

 

 

September 30,
2002

 

December 31,
2001

 

 

 

(Unaudited)

 

 

 

Assets

 

 

 

 

 

Current Assets

 

 

 

 

 

Cash and cash equivalents

 

$

10,763

 

$

15,587

 

Investment securities, available-for-sale

 

9,719

 

18,065

 

Accounts receivable, net of allowances of $109 and $109

 

2,703

 

1,712

 

Costs and estimated earnings in excess of billings on uncompleted contracts

 

1,797

 

1,584

 

Inventory, net

 

994

 

99

 

Current restricted investments

 

11

 

102

 

Other current assets

 

3,096

 

2,302

 

Total current assets

 

29,083

 

39,451

 

 

 

 

 

 

 

Long-term investment, at cost

 

 

624

 

Property and equipment, net

 

8,027

 

8,960

 

Restricted investments

 

1,356

 

1,434

 

Receivables from related parties, net

 

2,243

 

2,252

 

Other assets

 

568

 

1,334

 

Total assets

 

$

41,277

 

$

54,055

 

 

 

 

 

 

 

Liabilities, Minority Interests and Shareholders’ Equity

 

 

 

 

 

Current Liabilities

 

 

 

 

 

Accounts payable

 

$

1,942

 

$

1,613

 

Accrued liabilities

 

4,893

 

4,298

 

Allowance for estimated contract losses

 

155

 

155

 

Billings in excess of costs and estimated earnings on uncompleted contracts

 

179

 

60

 

Current portion of capital lease obligations

 

91

 

170

 

Current portion of long-term debt

 

62

 

57

 

Total current liabilities

 

7,322

 

6,353

 

 

 

 

 

 

 

Capital lease obligations, net of current portion

 

97

 

61

 

Long-term debt, net of current portion

 

185

 

232

 

Deferred rent, net of current portion

 

271

 

259

 

Total liabilities

 

7,875

 

6,905

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

 

Minority Interests

 

9,176

 

14,824

 

 

 

 

 

 

 

Shareholders’ Equity

 

 

 

 

 

Common stock and paid-in capital, no par value, 31,250 shares authorized; 15,154 and 12,998 shares issued and outstanding

 

147,042

 

135,954

 

Deferred compensation

 

(1,693

)

(2,803

)

Subscriptions receivable from related parties

 

(183

)

(321

)

Accumulated other comprehensive income

 

266

 

427

 

Accumulated deficit

 

(121,206

)

(100,931

)

Total shareholders’ equity

 

24,226

 

32,326

 

Total liabilities, minority interests and shareholders’ equity

 

$

41,277

 

$

54,055

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

3



 

Microvision, Inc.

 

Consolidated Statement of Operations

(In thousands, except earnings per share data)

(Unaudited)

 

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

 

2002

 

2001

 

2002

 

2001

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

4,186

 

$

2,402

 

$

12,724

 

$

6,511

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

1,919

 

1,338

 

5,925

 

3,981

 

Gross margin

 

2,267

 

1,064

 

6,799

 

2,530

 

 

 

 

 

 

 

 

 

 

 

Research and development expense (exclusive of non-cash compensation expense of $253 and $257 for the three months and $753 and $608 for the nine months ended September 30, 2002 and 2001, respectively)

 

5,433

 

8,479

 

18,762

 

24,489

 

 

 

 

 

 

 

 

 

 

 

Marketing, general and administrative expense (exclusive of non-cash compensation expense of $197 and $294 for the three months and $610 and $1,261 for the nine months ended September 30, 2002 and 2001, respectively)

 

3,904

 

3,816

 

12,786

 

10,820

 

Non-cash compensation expense

 

450

 

551

 

1,363

 

1,869

 

Total operating expenses

 

9,787

 

12,846